Header Logo

Connection

WOLFGANG WINKELMAYER to Prevalence

Back to Details
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Prevalence.
WOLFGANG WINKELMAYER
Connection Strength
0.632
Prevalence
  1. Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications. Clin J Am Soc Nephrol. 2021 10; 16(10):1562-1564.
    View in: PubMed
    Score: 0.118
  2. Outcomes after kidney transplantation of patients previously diagnosed with atrial fibrillation. Am J Transplant. 2013 Jun; 13(6):1566-75.
    View in: PubMed
    Score: 0.068
  3. Prevalence of atrial fibrillation and warfarin use in older patients receiving hemodialysis. J Nephrol. 2012 May-Jun; 25(3):341-53.
    View in: PubMed
    Score: 0.063
  4. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb; 22(2):349-57.
    View in: PubMed
    Score: 0.057
  5. Pottransplantation anemia: management and rationale. Clin J Am Soc Nephrol. 2008 Mar; 3 Suppl 2:S49-55.
    View in: PubMed
    Score: 0.047
  6. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol. 2004 May; 15(5):1347-52.
    View in: PubMed
    Score: 0.036
  7. Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate. JAMA Netw Open. 2022 02 01; 5(2):e220460.
    View in: PubMed
    Score: 0.031
  8. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
    View in: PubMed
    Score: 0.029
  9. Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 10; 96(4):836-849.
    View in: PubMed
    Score: 0.026
  10. Antidiabetic medication use in patients with type 2 diabetes and chronic kidney disease. J Diabetes Complications. 2019 11; 33(11):107423.
    View in: PubMed
    Score: 0.026
  11. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 06; 95(6):1304-1317.
    View in: PubMed
    Score: 0.025
  12. Common Elements in Rare Kidney Diseases: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2017 10; 92(4):796-808.
    View in: PubMed
    Score: 0.023
  13. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan; 25(1):90-9.
    View in: PubMed
    Score: 0.020
  14. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. Clin J Am Soc Nephrol. 2013 Dec; 8(12):2149-57.
    View in: PubMed
    Score: 0.017
  15. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013 Mar; 65(3):753-63.
    View in: PubMed
    Score: 0.017
  16. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012 Aug; 64(8):2669-76.
    View in: PubMed
    Score: 0.016
  17. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.